NDM-1-Positive <i>K. pneumoniae</i> at a Teaching Hospital in Southwestern China: Clinical Characteristics, Antimicrobial Resistance, Molecular Characterization, Biofilm Assay, and Virulence

<table class="table-group" id="tab2"><tr><td><table class="table"><tr><td class="thead-hr" colspan="3"><hr/></td></tr><tr class="thead"><td class="align_left" rowspan="2"> </td><td class="align_center" colspan="2">NDM-1-positive <i>K. pneumoniae</i> (<i>n</i> = 30)</td></tr><tr class="thead"><td class="align_center">No.</td><td class="align_center">%</td></tr><tr><td class="thead-hr" colspan="3"><hr/></td></tr><tr><td class="align_left">Meropenem</td><td class="align_center">30</td><td class="align_center">100%</td></tr><tr><td class="align_left">Imipenem</td><td class="align_center">30</td><td class="align_center">100%</td></tr><tr><td class="align_left">Ertapenem</td><td class="align_center">30</td><td class="align_center">100%</td></tr><tr><td class="align_left">Ceftazidime</td><td class="align_center">30</td><td class="align_center">100%</td></tr><tr><td class="align_left">Cefoperazone sulbactam</td><td class="align_center">30</td><td class="align_center">100%</td></tr><tr><td class="align_left">Piperacillin and sulbactam</td><td class="align_center">30</td><td class="align_center">100%</td></tr><tr><td class="align_left">Cefazolin</td><td class="align_center">30</td><td class="align_center">100%</td></tr><tr><td class="align_left">Cefepime</td><td class="align_center">30</td><td class="align_center">100%</td></tr><tr><td class="align_left">Cefoxitin</td><td class="align_center">30</td><td class="align_center">100%</td></tr><tr><td class="align_left">Ciprofloxacin</td><td class="align_center">26</td><td class="align_center">86.67%</td></tr><tr><td class="align_left">Aztreonam</td><td class="align_center">26</td><td class="align_center">86.67%</td></tr><tr><td class="align_left">Levofloxacin</td><td class="align_center">23</td><td class="align_center">76.67%</td></tr><tr><td class="align_left">Gentamicin</td><td class="align_center">22</td><td class="align_center">73.33%</td></tr><tr><td class="align_left">Amikacin</td><td class="align_center">17</td><td class="align_center">56.67%</td></tr><tr><td class="align_left">Sulfamethoxazole/trimethoprim</td><td class="align_center">10</td><td class="align_center">33.30%</td></tr><tr><td class="align_left">Polymyxin B</td><td class="align_center">0</td><td class="align_center">0</td></tr><tr><td class="align_left">Tigecycline</td><td class="align_center">0</td><td class="align_center">0</td></tr><tr class="table-tr"><td colspan="3"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

<div>The antimicrobial resistance profiling of NDM-1-positive <i>K. pneumoniae</i></div>

Canadian Journal of Infectious Diseases and Medical Microbiology

tab2

Table 2

Table 2: NDM-1-Positive <i>K. pneumoniae</i> at a Teaching Hospital in Southwestern China: Clinical Characteristics, Antimicrobial Resistance, Molecular Characterization, Biofilm Assay, and Virulence 

Table 2 | NDM-1-Positive K. pneumoniae at a Teaching Hospital in Southwestern China: Clinical Characteristics, Antimicrobial Resistance, Molecular Characterization, Biofilm Assay, and Virulence 